Samsung Biologics Signs 287 Bln Won CMO Supply Deal with GSK
Samsung Biologics Co. on Friday said that it signed an eight-year contract manufacturing organization (CMO) deal valued at 287 billion ...
Samsung Biologics Co. on Friday said that it signed an eight-year contract manufacturing organization (CMO) deal valued at 287 billion ...
CEO of Samsung Biologics Kim Tae-han said on Wednesday that he expects the company to take on contract deals for ...
WooGene Bio, a subsidiary of Woojin B&G, announced on Monday that it has attracted $8.86B USD (1 billion won) in ...
Copyright © 2024 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : press@koreatechtoday.com |